CIK 0001771910 · Non-accelerated filer<br>Smaller reporting company
ADC Therapeutics SA
Sign in to watch- Ticker
- ADCT
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- Phone
- 41 21 653 02 00
- Business address
- BIOPOLE, ROUTE DE LA CORNICHE 3B, EPALINGES, Switzerland, 1066
- 4 Grant or award Chief Financial Officer acquired 240,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 650,000 shares (grant or award)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Open-market buy 10% owner bought 200,000 shares at an average $3.05 ($609,000)
- 4 Shares withheld for taxes Chief Medical Officer gave up 37,112 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 6,503 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 48,108 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 41,458 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 238,343 shares (to pay taxes)
- 4 Open-market sale 10% owner sold 25,352 shares at $2.07 ($52,479)
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Shareholder vote results
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
Page 7 of 23 · 441 filings